Skip to content
DataLookout
Menu

CTEPHNCT06865326

Early Detection of CTEPH in Patients After APE

StatusRecruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from May 31, 2026 to Dec 31, 2027
    • Eligibility criteria expanded, about 15 words
    • Study completion pushed from Dec 1, 2026 to Jun 30, 2028
    • Study description revised
  2. Notable Phase: Not applicable to Not specifiedv2 Show 4 more changesShow less
    • Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 10
    • Start date changed from estimate of Feb 28, 2025 to Mar 7, 2025
    • Study description revised
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Positive predictive value of initial examination
Timeframe: Up to six months from enrollment
CTEPH detection rates
Timeframe: Up to six months from enrollment
Proportion of people with suspected CTEPH who attended a follow-up examination at a specialized pulmonary hypertension treatment centre
Timeframe: Up to six months from enrollment

Arms and interventions

CTEPH Screening Arm

Patients after APE matching all inclusion \& exclusion criteria will undergo a standardized screening process for early detection of CTEPH. The process will include the new screening protocol and in case of a risk of CTEPH, transfer to specialized center for further management.

Other: Standardized CTEPH Screening Protocol

Sites

10 sites in 1 country